Literature DB >> 8063749

Activation of ribosomal protein S6 kinases does not increase glycogen synthesis or glucose transport in rat adipocytes.

T A Lin1, J C Lawrence.   

Abstract

Rat adipocytes were incubated with insulin or epidermal growth factor (EGF) before the mitogen-activated protein (MAP) kinases, ERK-1 and ERK-2, and the ribosomal protein S6 kinases, Rsk-2 and p70S6K, were resolved by ion exchange chromatography and identified by immunoblotting. EGF was more effective than insulin in increasing the activity of two kinases that reacted with Rsk-2 antibody (2- and 2.5-fold with EGF versus 1.6- and 1.2-fold with insulin). EGF was also more effective than insulin in increasing the activity of ERK-1 (5-fold versus 2-fold) and ERK-2 (2.5-fold versus 1.5 fold). The activity of p70S6K was increased by approximately the same extent by EGF and insulin (1.7-fold versus 2-fold). Rapamycin blocked activation of p70S6K by insulin, but it did not attenuate the effect (2-fold) of insulin on increasing the glycogen synthase activity ratio (+/-glucose-6-P). Insulin increased glucose incorporation into glycogen and 2-deoxyglucose uptake by approximately 5-fold, whereas EGF and phorbol 12-myristate were without effect. Thus, activation of MAP kinases and ribosomal protein S6 kinases appears insufficient to activate glycogen synthase or glucose transport, the two key components in the stimulation of glycogen synthesis by insulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063749

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats.

Authors:  S Bhanot; J Girn; P Poucheret; J H McNeill
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Keep nibbling at the edges.

Authors:  Philip Cohen
Journal:  J Biol Chem       Date:  2009-06-10       Impact factor: 5.157

Review 3.  Insulin signal transduction through protein kinase cascades.

Authors:  J Avruch
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

4.  3T3-L1 adipocytes as a cell culture model of insulin resistance.

Authors:  V P Knutson; Y Balba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

Review 5.  Spatial determinants of specificity in insulin action.

Authors:  C C Mastick; M J Brady; J A Printen; V Ribon; A R Saltiel
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

6.  Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases.

Authors:  S K Pandey; J L Chiasson; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

7.  Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice.

Authors:  S D Dufresne; C Bjørbaek; K El-Haschimi; Y Zhao; W G Aschenbach; D E Moller; L J Goodyear
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

8.  Multiple mechanisms for the phosphorylation of C-terminal regulatory sites in rabbit muscle glycogen synthase expressed in COS cells.

Authors:  A V Skurat; P J Roach
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

9.  Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells.

Authors:  T A Diggle; S K Moule; M B Avison; A Flynn; E J Foulstone; C G Proud; R M Denton
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

10.  Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase.

Authors:  P R Shepherd; B T Navé; K Siddle
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.